| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 5 |
| 1 | ETANERCEPT | 4 |
| 2 | GABAPENTIN | 4 |
| 3 | INTERFERON BETA-1A | 4 |
| 4 | ASPIRIN | 3 |
| 5 | ASPIRIN 325 MG | 3 |
| 6 | ASPIRIN 81 MG | 3 |
| 7 | ERGOCALCIFEROL | 3 |
| 8 | ORAL SEMAGLUTIDE | 3 |
| 9 | RISANKIZUMAB-RZAA | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 1 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 2 | OSILODROSTAT | 2 | 0.0009 |
| 3 | LEVOMILNACIPRAN HYDROCHLORIDE | 1 | 0.0005 |
| 4 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 5 | FERRIC CARBOXYMALTOSE | 1 | 0.0002 |
| 6 | PRAZOSIN | 1 | 0.0002 |
| 7 | C1 ESTERASE INHIBITOR RECOMBINANT | 1 | 0.0002 |
| 8 | BENAZEPRIL HYDROCHLORIDE | 1 | 0.0001 |
| 9 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 5 |
| 2 | Benzodiazepine [EPC] | 4 |
| 3 | Interferon beta [EPC] | 4 |
| 4 | Estrogen [EPC] | 3 |
| 5 | GLP-1 Receptor Agonist [EPC] | 3 |
| 6 | Janus Kinase Inhibitor [EPC] | 3 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 3 |
| 8 | Vitamin C [EPC] | 3 |
| 9 | Corticosteroid [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 1 | Progesterone [EPC] | 1 | 0.0000 |
| 2 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 5 | Muscle Relaxant [EPC] | 1 | 0.0000 |
| 6 | Insulin [EPC] | 1 | 0.0000 |
| 7 | Interferon beta [EPC] | 4 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Estrogen [EPC] | 3 | 0.0000 |